Our work provides evidences of a potential role played by circulating CD4+ TEM and CD8+ TEF and TEMRA lymphocytes and pro-inflammatory cytokines at the onset of T1R in BL patients. This evidence concerns the gene CD8A and Burkitt lymphoma.